Literature DB >> 33610674

Minireview: Mas-related G protein-coupled receptor X2 activation by therapeutic drugs.

Benjamin D McNeil1.   

Abstract

Symptoms that resemble allergic reactions, such as pruritus, flushing, and hypotension, are common side effects of therapeutic drugs. In a true allergic reaction, Immunoglobulin E (IgE) antibodies recognize the drug and trigger mediator release from mast cells through cross-linking of IgE receptors. However, many drugs can bypass this pathway and can activate mast cells directly through MRGPRX2, a G protein-coupled receptor that responds to a wide range of small molecules, peptides, and proteins that have little in common except for a net positive charge. This review will provide an overview of MRGPRX2, including its expression pattern, studies of its pharmacology, and its orthologs. It also will review evidence for MRGPRX2 activation by many drugs closely associated with these reactions.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Anaphylaxis; Flare; IgE-independent; Immediate hypersensitivity; MRGPRX2; Mast cells; Mrgprb2; Pruritus; Pseudo-allergic; Wheal

Mesh:

Substances:

Year:  2021        PMID: 33610674     DOI: 10.1016/j.neulet.2021.135746

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

Review 1.  Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.

Authors:  Saptarshi Roy; Chalatip Chompunud Na Ayudhya; Monica Thapaliya; Vishwa Deepak; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2021-05-04       Impact factor: 14.290

Review 2.  Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.

Authors:  Hiroyuki Ogasawara; Masato Noguchi
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.